N/A
- Pharmaceuticals
- Actinic Prurigo Treatment Market
Actinic Prurigo Treatment Market
Actinic Prurigo Treatment Market - Global Industry Trend Analysis 2015 to 2019 and Forecast 2020 - 2028
Market Overview
Actinic prurigo, also known as sun allergy or Hutchinson prurigo, is a condition of the skin reaction triggered by sunlight. These changes cause the immune system to incorrectly identify the proteins in the skin cells as damaging invaders. The symptoms included are severe itching and painful inflammation of sun-exposed skin, for some people the reactions are severe which results to the formation of small blisters or hives that often spreads unto the skin’s clothed areas.
According to the British Association of Dermatologists, women are more susceptible to actinic prurigo than men, by the ratio of 2:1. Besides, actinic prurigo affects all skin types but more commonly the Latin American and American Indians of darker skin tone.
Therefore, it’s common in Central and South America and Mexico, where it often affects people who are residing at high altitude. It is rarely in Europe and Asia. The global actinic prurigo treatment market is expected to grow further due to its increasing prevalence, rising awareness and availability of medical advanced treatments.
Coronavirus has negatively impacted several economies and industries including the actinic prurigo, with the massive imposition of lockdown, temporary shutdown of industries and offices. The R&D funds and research focus has been diverted to COVID-19 vaccine development, which has staggered the growth of other medical research areas such as actinic prurigo. However, with the restoration of normalcy in the market and medical research areas, the actinic prurigo treatment market is expected to leverage in future.
Growing cases of allergic disorders is the primary factory driving the growth of actinic prurigo market. Moreover, inclination toward advance technologies also boosting the revenue growth for the market. For instance, thalidomide has been described as the hallmark therapy for severe refractory cases of actinic prurigo.
Treatment with thalidomide has a major limiting side effect profile, which includes peripheral neuropathy and teratogenicity, which will further contribute to drive the market for actinic prurigo in the near future. Although, with the advancing medical treatments of actinic prurigo and its escalating research and rising awareness, the global actinic prurigo treatment market is expected to elevate further.
However, allergy treatment is majorly hamper by side effects of anti-allergy drugs coupled with high treatment cost is the major challenge that will limit the market growth.
The report covers exhaustive analysis on:
- Actinic Prurigo Treatment Market Segments
- Actinic Prurigo Treatment Market Dynamics
- Historical Actual Market Size, 2015 - 2019
- Actinic Prurigo Treatment Market Size & Forecast 2020 to 2030
- Actinic Prurigo Treatment Current Trends/Issues/Challenges
- Competition & Companies involved
- Actinic Prurigo Treatment Market Drivers and Restraints
Regional analysis includes
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East & Africa
Report Highlights:
- Shifting Industry dynamics
- In-depth market segmentation
- Historical, current and projected industry size Recent industry trends
- Key Competition landscape
- Strategies for key players and product offerings
- Potential and niche segments/regions exhibiting promising growth
- A neutral perspective towards market performance
